{"id":55227,"date":"2025-07-30T08:39:48","date_gmt":"2025-07-30T08:39:48","guid":{"rendered":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/"},"modified":"2025-07-30T08:39:48","modified_gmt":"2025-07-30T08:39:48","slug":"ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/","title":{"rendered":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS"},"content":{"rendered":"<p>JOS\u00c9 MIGUEL JURADO GARC\u00cdA &#8211; ENSAYO CLINICO CON MEDICAMENTOS &#8211; III &#8211; FUNDACI\u00d3N GECP<\/p>","protected":false},"excerpt":{"rendered":"<p>JOS\u00c9 MIGUEL JURADO GARC\u00cdA &#8211; ENSAYO CLINICO CON MEDICAMENTOS &#8211; III &#8211; FUNDACI\u00d3N GECP<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2683],"tags":[],"class_list":["post-55227","post","type-post","status-publish","format-standard","hentry","category-ensayos-clinicos","category-ensayos-clinicos-b-22"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima\" \/>\n<meta property=\"og:description\" content=\"JOS\u00c9 MIGUEL JURADO GARC\u00cdA &#8211; ENSAYO CLINICO CON MEDICAMENTOS &#8211; III &#8211; FUNDACI\u00d3N GECP\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T08:39:48+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS\",\"datePublished\":\"2025-07-30T08:39:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/\"},\"wordCount\":63,\"commentCount\":0,\"articleSection\":[\"Ensayos Cl\u00ednicos\",\"Ensayos Cl\u00ednicos - B-22\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/\",\"name\":\"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2025-07-30T08:39:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/","og_locale":"en_GB","og_type":"article","og_title":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima","og_description":"JOS\u00c9 MIGUEL JURADO GARC\u00cdA &#8211; ENSAYO CLINICO CON MEDICAMENTOS &#8211; III &#8211; FUNDACI\u00d3N GECP","og_url":"https:\/\/ibima.eu\/en\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/","og_site_name":"Ibima","article_published_time":"2025-07-30T08:39:48+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS","datePublished":"2025-07-30T08:39:48+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/"},"wordCount":63,"commentCount":0,"articleSection":["Ensayos Cl\u00ednicos","Ensayos Cl\u00ednicos - B-22"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/","url":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/","name":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2025-07-30T08:39:48+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/ensayo-clinico-fase-ii-de-quimio-inmunoterapia-neoadyuvante-seguida-de-tratamiento-adyuvante-segun-el-estado-de-reseccion-para-el-tratamiento-de-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-co\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Ensayo cl\u00ednico fase II de quimio-inmunoterapia neoadyuvante seguida de tratamiento adyuvante seg\u00fan el estado de resecci\u00f3n para el tratamiento de pacientes con c\u00e1ncer de pulm\u00f3n no microc\u00edtico (CPNM) con diagn\u00f3stico de tumor de pancoast. Un estudio exploratorio multic\u00e9ntrico. DUMAS"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/55227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=55227"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/55227\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=55227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=55227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=55227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}